FDA issues psychedelic therapy guidance as Clearmind notes federal push
Go back to FDA issues psychedelic therapy guidance as Clearmind notes federal push| (NASDAQ: CMND) | Delayed: 0.78 -0.02 (2.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.80 | 52 Week High | $ | |||
| Open | $0.79 | 52 Week Low | $ | |||
| Day High | $0.80 | P/E | N/A | |||
| Day Low | $0.78 | EPS | $ | |||
| Volume | 82,364 | |||||

